Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
That distinction affects consent, safety monitoring, and accountability
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
PMC 6210286
This content is for informational purposes only and is not a substitute for professional medical advice
US$ 27.83
US$ 24.02
US$ 24.06
/assets/images/provider/photos/2800172.png)
US$ 23.30
US$ 28.86
US$ 26.46
US$ 23.40
US$ 24.92
US$ 20.01
US$ 23.07
US$ 28.57
